Combinations of potassium channel activator and mc4r agonist
CL202601558A1Pending Publication Date: 2026-08-21RHYTHM PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CL202601558
- Authority / Receiving Office
- CL · CL
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-11-14
- Filing Date
- 2026-05-12
- Publication Date
- 2026-08-21
Abstract
The description refers to a method for treating a disease or disorder in a subject by the use of a combination of: (i) a potassium channel activator (e.g., a compound (ii) an agonist of the SURx / Kirx channel) or a pharmaceutically acceptable salt thereof; and (ii) an agonist of the melanocortin-4 receptor (MC4R).
Need to check novelty before this filing date? Find Prior Art